Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (161-170 of 238) with videos related to

Pageof 24
Sort By:
Annals of the Rheumatic Diseases|February 7, 2025
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1<sup>+</sup> monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.
Seminars in Arthritis and Rheumatism|July 2, 2026
Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosisAradhna Agarwal, Dahlia Hassan, Suiyuan Huang, et al.
Plos One|September 4, 2014
Association of the HLA-DRB1 with scleroderma in Chinese populationDongyi He, Jiucun Wang, Lin Yi, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
Annals of the Rheumatic Diseases|September 19, 2024
Human hypofunctional <i>NCF1</i> variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1<sup>+</sup> monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
BMJ Open|March 8, 2018
Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort studyErin L Merz, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
Pageof 24

Showing results (161-170 of 238) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|February 7, 2025
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1<sup>+</sup> monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.
Seminars in Arthritis and Rheumatism|July 2, 2026
Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosisAradhna Agarwal, Dahlia Hassan, Suiyuan Huang, et al.
Plos One|September 4, 2014
Association of the HLA-DRB1 with scleroderma in Chinese populationDongyi He, Jiucun Wang, Lin Yi, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
Annals of the Rheumatic Diseases|September 19, 2024
Human hypofunctional <i>NCF1</i> variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1<sup>+</sup> monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2020
Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung FibrosisChiara Bellocchi, Jun Ying, Ellen A Goldmuntz, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
BMJ Open|March 8, 2018
Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort studyErin L Merz, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
Pageof 24